Trade Pfizer ^PFE

Pfizer (NYSE:PFE) Shares Down 1.3% - Here's What Happened

Pfizer (PFE) Secures Patent Settlement, Extending Vyndamax Protection

Pfizer (PFE) Confirms Tafamidis Settlement, Shares Receive Boost

Company Website: https://www.pfizer.com NEW YORK -- (Busin

Pfizer Settles Patent Disputes, Extends VYNDAMAX Exclusivity To 2031

Pfizer Drops Hikma From Vyndamax Patent Lawsuit, Ending Trial

Pfizer (PFE) Secures Tafamidis Patent Extension Through 2031

Direct Relief and the Pfizer Foundation Announce New Grantees in Fifth Year of Infectious Disease Program

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Pfizer Reaches Three Settlement Agreements for VYNDAMAX | Morningstar

Are Wall Street Analysts Bullish on Pfizer Stock?

Merck Broadens Growth Story With Heart Campaign And New Drug Approvals

Pfizer (PFE) Projected to Post Earnings on Tuesday

ESR1 Mutated Metastatic Breast Cancer Market Research Report 2026: Epidemiological Analysis, Competitive Landscape, Regulatory Landscape, Pipeline Analysis, M&A, Regulatory Activities, Funding,

Pancreatic Neuroendocrine Tumors Market Research Report 2025-2035, Competitive Analysis of Key Players - Novartis, Pfizer, Exelixis, Merck, Ipsen Pharma, and Takeda Pharma

Relay Therapeutics Unveils Zovegalisib Triplet Data, Signs Pfizer Supply Deal for Phase III Plan

Pfizer identifies new GIPR antagonists | BioWorld

Pfizer (PFE) Valuation Check After New Oncology Data And Priority Review For Cancer Regimen

The clinical landscape of HIF2α inhibitors in oncology

Is Pfizer (PFE) One of the Best Fortune 500 Dividend Stocks to Invest in Right Now?

Branded Pharmaceuticals Stocks Q4 Results: Benchmarking Supernus Pharmaceuticals (NASDAQ:SUPN)

Piper Sandler: Fed Likely to Maintain Current Interest Rates Amid Economic Stability

Pfizer's Foes in Bench Trial Over Vyndamax Copies Down to Hikma

Pfizer's (PFE) Zovegalisib Advances to Phase 3 for Breast Cancer Treatment

Is Bristol Myers Squibb the Best Bargain in Big Pharma?

Pfizer Inc. $PFE Shares Sold by Comerica Bank

Pfizer Inc. $PFE Shares Sold by D.A. Davidson & CO.

Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast Cancer

Pfizer AGM: Shareholders Reject Independent Chair Proposal as Bourla Touts 2025 Gains and Pipeline

If You Believe In Transformative AI Healthcare Then These Three Stocks Could Define Your Next Cycle

Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial

Chronic myelomonocytic leukemia beyond the marrow: biology, patterns, and management of extramedullary disease

GSK plc (GSK): The Vaccine Sentinel Faces a Critical Pivot Toward Specialty Mastery

Top Pharmaceutical Stocks To Keep An Eye On - April 26th - Daily Political

Pfizer Inc. $PFE Shares Sold by M&T Bank Corp

Advisors Capital Management LLC Raises Holdings in Pfizer Inc. $PFE

Vanguard Group Inc. Raises Stock Position in Pfizer Inc. $PFE - Daily Political

Pfizer (NYSE:PFE) Trading Up 1.3% - Should You Buy? - Daily Political

Pfizer Tests Transparent Eliquis Pricing As Valuation Signals Undervaluation

Pfizer Eliquis Price Move With Cost Plus Raises Questions On Valuation

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy

Editorial | Influx of global firms underscores Hong Kong's economic recovery

BridgeBio (BBIO) Shares Rise Following Positive Patent Settlement News

Bristol Myers, Pfizer Bring Eliquis to Cost Plus at $345 Monthly

SBI Funds Management buys 2% stake in ADF Foods, ICICI Prudential MF picks up additional Pfizer shares worth Rs 188 crore

Wall Street Says Buy Merck Over Pfizer. The Numbers Tell a More Complicated Story.

Pfizer Inc. (PFE): One of the Best Safe Stocks to Invest in for Beginners

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Bristol Myers, Pfizer to Offer Discounted Eliquis on Mark Cuban's Cost Plus Drug | Morningstar

Pfizer Obesity Pipeline Expands As Monthly GLP 1 Candidate Targets Growth

Pfizer Inc. $PFE Shares Sold by Arizona State Retirement System

Pfizer presents auristatin S ADC for GPNMB tumors | BioWorld

Momentum Stocks: Himadri Speciality, Adani Ports hits 52-week high; JK Tyre, Pfizer see negative breakdowns

Novo Nordisk Expands GLP-1 Reach With Pediatric Oral Semaglutide Data

Torray Investment Partners LLC Boosts Stake in Pfizer Inc. $PFE

Pharmaceutical Stocks Worth Watching - April 23rd - Stock Observer

Want $4,200 in Passive Income? Invest $90,000 ($30,000 Each) Into These 3 High-Yield Dividend Stocks

Pfizer Inc. $PFE Shares Sold by Mystic Asset Management Inc.

Pfizer Inc. to Issue Quarterly Dividend of $0.43 (NYSE:PFE)

Pfizer Inc. $PFE Holdings Cut by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA - Daily Political

Pfizer Inc. (NYSE:PFE) Receives Average Recommendation of "Hold" from Brokerages

ASC4OPT: asciminib treatment optimization study in patients with chronic myeloid leukemia in chronic phase previously treated with two or more tyrosine kinase inhibitors

Innovation Q&A: LI Qiang of Weican Medical - Transforming from Understanding to Establishing Rules in Reinventing Implantable Drug Delivery Path

Therapeutic Spp1 silencing in TREM2+ cardiac macrophages suppresses atrial fibrillation

Pfizer (PFE) Announces Quarterly Dividend of $0.43 Per Share

Pfizer (NYSE:PFE) Shares Down 1.9% - What's Next?

Should You Forget Pfizer and Buy This Pharma Stock Instead?

Pfizer to cut more than 100 jobs at Ringaskiddy plant in Cork

Pfizer challenges Novo and Lilly: GLP-1 drug available for pre-order in China

Pfizer GLP-1 weight loss drug available for pre-order in China

Drug Delivery Devices Market Insights, Competitive Landscape, and Forecast Report 2025-2032 - Growing Use of Biologics and Biosimilars, Technological Advancements, and Active Product Developments

Pfizer Oncology Pivot In Focus As ASCO 2026 Data And PADCEV Loom

Pfizer Inc. $PFE Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - Daily Political

Pfizer's ASCO Oncology Data Puts Future Cancer Revenue Story In Focus

Eli Lilly eyes Kelonia Therapeutics in $7B deal with $3.25B to be paid up front. How to invest early to grow your wealth

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer (PFE) Chief Strategy Officer to Depart by 2026

Top Pharmaceutical Stocks Worth Watching - April 21st - Daily Political

Analysis-COVID shots, newer vaccines in limbo after US court halts Kennedy's advisory panel

Brighton Jones LLC Decreases Stock Position in Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by Osborne Partners Capital Management LLC - Daily Political

Pfizer Oncology Outlook Shifts As PADCEV Keytruda Win Nears FDA Decision

CICC Initiates Coverage of Pfizer Inc. (PFE) With an Outperform Rating

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Pharmaceutical Stocks To Watch Now - April 20th - Markets Daily

Royal Bank Of Canada Reaffirms "Underperform" Rating for Pfizer (NYSE:PFE)

Pfizer Inc. $PFE Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank

Lecap Asset Management Ltd. Purchases Shares of 30,750 Pfizer Inc. $PFE

Lecap Asset Management Ltd. Buys New Shares in Pfizer Inc. $PFE - Markets Daily

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision

Stock price forecast: 4 S&P 500 Stocks for 2025

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Apple earnings land as Fed seen holding rates

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk